Multidisciplinary Team - medical, surgical and radiation oncologists, radiologists, pathologists, nurses, support staff, residents and interns make up the team of professionals who are involved in designing a patient specific approach to the treatment of a specific malignancy.
Weekly Pre-Treatment Planning Conference - a meeting of the multidisciplinary team who collectively review new and relapsed patient cases including pathology findings and diagnostic results to collaborate on treatment options and potential clinical trials available to the patient. These conferences ideally occur before a patient is started on treatment to ensure that the patients clinical, surgical and research options are fully explored before treatment begins.
Medical Oncology Services - oncologists trained in the diagnosis and management of malignancies using chemotherapy, biologic therapy, gene therapy and clinical research etc. as well as other approaches to manage the toxicity of therapy.
Radiation Oncology Services - oncologists trained in the use of radiation therapy, radiation seed implants, and other investigational techniques to deliver doses of radiation to malignant tumors and to areas of the body that may be at risk due to proximity to or invasion of the malignancy.
Surgical Oncology Services - surgeons trained in the diagnosis and surgical removal of malignancies as well as the surgical repair of areas where malignancies once existed
Complete Staging Evaluation - the evaluation of the degree of invasion of a malignancy which may include the area of the primary tumor, the tissues and organs that are in close proximity to the primary tumor as well as the assessment of all other major organs including skin and bone for involvement of tumor.
Complete Prognostic Testing - the review of factors that contribute to the knowledge about a certain malignancy, for example in the diagnosis of breast cancer the physician will review tumor size, the extent of tumor invasion to the lymph nodes and other structures, the presence of growth factors, the analysis of the tumors, DNA, etc., all which give a better indication of how the tumor will act.
Risk Counseling/Genetic Testing Program - Hereditary, Environmental and Behavioral Cancer Risk Counseling - the analysis of genetic risk by blood analysis (BRCA1 and 2) and the evaluation of breast cancer risk by review of family history, medical history, surgical history, and other factors is available. These factors are analyzed to determine if a woman is eligible to participate in cancer prevention trials and/or other interventions designed to reduce risk. A dedicated, experienced counselor works alongside with the patient.
Oncology Supportive Care Services are provided by psychologists, social workers, nutritionists and a support team. We offer: individual and family counseling as it relates to cancer, multiple support groups and pain management.
Case Management - medical insurance carriers will review the case with the physician's office to estimate the degree of care a patient is entitled to based on diagnosis.
Patient Navigator Program - Our Patient Navigator provides supportive services to all patients with any abnormal mammogram findings. The Patient Navigator also assists patients by alleviating any barriers through the healthcare system. A vital role of the program is to educate and train females and males of the importance of early detection.
For more information, please call 305.535.3384.
Patient and Family Education and Support - services and resources in place to assist patients and families and caregivers. Our support personnel provide education on specific cancer treatment options, coping mechanisms, and additional information on issues which patients and families go through while living with cancer.
Individual, Couple and Group Counseling - special sessions with psychologists and social workers designed to meet the emotional needs of individuals with cancer.
Access to Innovative Clinical Research Studies - state-of-the-art clinical trials are available including prevention trials for individuals at high risk for cancer. Participation in other clinical trials is available at the Mount Sinai Comprehensive Cancer Center through the Mount Sinai Community Clinical Oncology Program (CCOP). Access to the newest therapies, otherwise not available outside the context of a clinical trial, is available in most disease settings.